Diaceutics PLC (DXRX.L)
- Previous Close
103.00 - Open
103.00 - Bid 102.00 x --
- Ask --
- Day's Range
103.00 - 103.00 - 52 Week Range
79.00 - 110.00 - Volume
1,941 - Avg. Volume
56,168 - Market Cap (intraday)
87.22M - Beta (5Y Monthly) 0.45
- PE Ratio (TTM)
-- - EPS (TTM)
-0.00 - Earnings Date May 21, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
166.60
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
www.diaceutics.com151
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DXRX.L
Performance Overview: DXRX.L
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DXRX.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DXRX.L
Valuation Measures
Market Cap
87.22M
Enterprise Value
70.60M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.07
Price/Book (mrq)
2.12
Enterprise Value/Revenue
3.22
Enterprise Value/EBITDA
20.53
Financial Highlights
Profitability and Income Statement
Profit Margin
0.03%
Return on Assets (ttm)
-0.72%
Return on Equity (ttm)
0.01%
Revenue (ttm)
21.9M
Net Income Avi to Common (ttm)
6k
Diluted EPS (ttm)
-0.00
Balance Sheet and Cash Flow
Total Cash (mrq)
17.88M
Total Debt/Equity (mrq)
3.07%
Levered Free Cash Flow (ttm)
-2.31M
Research Analysis: DXRX.L
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: DXRX.L
DXRX.L does not have Company Insights